ATE348106T1 - Peptidanaloga abgeleitet vom tumornekrose-faktor- rezeptor - Google Patents

Peptidanaloga abgeleitet vom tumornekrose-faktor- rezeptor

Info

Publication number
ATE348106T1
ATE348106T1 AT98923839T AT98923839T ATE348106T1 AT E348106 T1 ATE348106 T1 AT E348106T1 AT 98923839 T AT98923839 T AT 98923839T AT 98923839 T AT98923839 T AT 98923839T AT E348106 T1 ATE348106 T1 AT E348106T1
Authority
AT
Austria
Prior art keywords
necrosis factor
tumor necrosis
factor receptor
tnf
peptide analogs
Prior art date
Application number
AT98923839T
Other languages
English (en)
Inventor
Mark I Greene
Ramachandran Murali
Wataru Takasaki
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Application granted granted Critical
Publication of ATE348106T1 publication Critical patent/ATE348106T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98923839T 1997-05-30 1998-05-29 Peptidanaloga abgeleitet vom tumornekrose-faktor- rezeptor ATE348106T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/866,545 US6265535B1 (en) 1997-05-30 1997-05-30 Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses

Publications (1)

Publication Number Publication Date
ATE348106T1 true ATE348106T1 (de) 2007-01-15

Family

ID=25347839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98923839T ATE348106T1 (de) 1997-05-30 1998-05-29 Peptidanaloga abgeleitet vom tumornekrose-faktor- rezeptor

Country Status (10)

Country Link
US (1) US6265535B1 (de)
EP (2) EP1011704B1 (de)
AT (1) ATE348106T1 (de)
AU (4) AU744925B2 (de)
CA (1) CA2291963C (de)
DE (1) DE69836638T2 (de)
DK (1) DK1011704T3 (de)
ES (1) ES2279575T3 (de)
PT (1) PT1011704E (de)
WO (1) WO1998053842A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19948867A1 (de) * 1998-10-09 2000-08-17 Bioserv Ag TNFalpha bindende Peptide und ihre Anwendung für Detektion, Inaktivierung und/oder Entfernung von TNFalpha aus biologischen Flüssigkeiten
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
AU773891C (en) 1998-10-23 2005-02-17 Kirin-Amgen Inc. Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
IL130989A0 (en) * 1999-07-20 2001-01-28 Compugen Ltd Variants of alternative splicing
US6673771B1 (en) 1999-07-28 2004-01-06 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclast activity
US6682739B1 (en) * 1999-07-28 2004-01-27 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclastogenesis
AU777634B2 (en) * 1999-07-28 2004-10-28 Kazuhiro Aoki Methods of inhibiting osteoclastogenesis
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
BR0112969A (pt) * 2000-08-04 2004-06-22 Dmi Biosciences Inc Método de utilização de dicetopiperazinas e composições contendo-as
DK2295081T3 (en) 2001-06-26 2019-02-18 Amgen Inc Antibodies to OPGL
EP1513543B1 (de) * 2002-05-23 2010-10-06 The Trustees of The University of Pennsylvania Fas peptid-mimetika und ihre verwendungszwecke
EP1545608A4 (de) 2002-06-28 2006-09-13 Centocor Inc Ch1-deletierte säugetier-mimetikörper, zusammensetzungen, verfahren und anwendungen
WO2004030522A2 (en) * 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnosis and monitoring of diseases
ES2572454T3 (es) * 2003-05-15 2016-05-31 Ampio Pharmaceuticals Inc Tratamiento de enfermedades mediadas por los linfocitos T
JP5021317B2 (ja) * 2003-12-30 2012-09-05 スリーエム イノベイティブ プロパティズ カンパニー フルオロポリマーの凝集方法および組成物
JP2008505928A (ja) 2004-07-08 2008-02-28 アムジェン　インコーポレーテッド 治療用ペプチド
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
BR112012013330A2 (pt) * 2009-12-02 2017-03-28 Acceleron Pharma Inc composições e métodos para aumentar meia vida do soro de proteínas de fusão fc
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
DK2684888T3 (da) * 2011-03-09 2019-08-19 Jitsubo Co Ltd Nye tværbundne peptider indeholdende ikke-peptid-tværbundet struktur, fremgangsmåde til syntetisering af tværbundne peptider og ny organisk forbindelse anvendt i fremgangsmåden
WO2012170938A1 (en) 2011-06-08 2012-12-13 Acceleron Pharma Inc. Compositions and methods for increasing serum half-life
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
WO2013055734A1 (en) 2011-10-10 2013-04-18 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
CA2846394A1 (en) 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
JP6723222B2 (ja) 2014-08-18 2020-07-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 関節病態の治療
EP3310375A4 (de) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Verwendung von niedermolekularen fraktionen von humanem serumalbumin bei der behandlung von erkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO812612L (no) 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses

Also Published As

Publication number Publication date
PT1011704E (pt) 2007-03-30
EP1011704A1 (de) 2000-06-28
AU2005200634A1 (en) 2005-03-17
DE69836638T2 (de) 2007-10-04
DK1011704T3 (da) 2007-04-23
AU2008243270B2 (en) 2011-09-01
CA2291963A1 (en) 1998-12-03
DE69836638D1 (de) 2007-01-25
ES2279575T3 (es) 2007-08-16
AU744925B2 (en) 2002-03-07
EP1011704A4 (de) 2002-07-31
AU2008243270A1 (en) 2008-12-11
AU778124B2 (en) 2004-11-18
AU7603698A (en) 1998-12-30
EP1837344A1 (de) 2007-09-26
AU4584402A (en) 2002-07-25
WO1998053842A1 (en) 1998-12-03
US6265535B1 (en) 2001-07-24
CA2291963C (en) 2011-04-19
EP1011704B1 (de) 2006-12-13

Similar Documents

Publication Publication Date Title
ATE348106T1 (de) Peptidanaloga abgeleitet vom tumornekrose-faktor- rezeptor
BR9812096A (pt) Proteìna receptora/ligante solúvel interleucina-6 quimérica, seus análogos e seus usos
ATE168415T1 (de) Wasserlösliche peptidanaloguen mit bindungstellen
ATE338121T1 (de) Von muc-1 abgeleitete peptide
WO2003070747A3 (en) Insulin and igf-1 receptor agonists and antagonists
PL346443A1 (en) Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
ATE362982T1 (de) ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET
EP1009804A4 (de) Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
DE60335216D1 (de) Adiponektin-rezeptor und dafür kodierendes gen
CA2530027A1 (en) Novel melanocortin receptor templates, peptides, and use thereof
DE60014575D1 (de) Stabilisierende Peptide, und Polypeptide und Antikörper die diese beinhalten
DE69715181D1 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
DK258789D0 (da) Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet
ES2129120T3 (es) Un receptor de celulas t humanas de la familia de receptores acoplados a la proteina g.
MX9203175A (es) Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion.
ATE412670T1 (de) Parathyroid hormon (pth) polypeptidderivate
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
DE69925116D1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
ATE291033T1 (de) Therapeutische peptide
ATE442444T1 (de) Glykosylphosphatidylinositolhaltige polypeptide
EP0717752A4 (de) Therapeitische inhaltsstoffe
Cody et al. Modifications of the C-Terminal Dipeptide of Angiotensin II Yielded a Novel Series of Analogues with Type II (AT~ 2) Receptor Selectivity
ATE163652T1 (de) Antikörper gegen das carboxy-terminale peptid des somatotropin-bindungsproteins der ratte
WO1999027097A3 (en) CLONING OF A TETRODOTOXIN-RESISTANT SODIUM CHANNEL α-SUBUNIT
EA200400384A1 (ru) Растворимый рецептор т-клетки

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1011704

Country of ref document: EP

REN Ceased due to non-payment of the annual fee